immune system
• The expression of CXCL1, CXCL2, CCL2, and CCL5, but not CCL20, is significantly reduced
|
• IL17A producing T cells are significantly increased in inguinal lymph nodes and spleens
|
• a delay in disease onset as well as reduced disease severity in the MOG peptide induced EAE
|
• decrease in the total number of immune cells infiltrating the brain and spinal cord in response to MOG peptide
|
homeostasis/metabolism
• The expression of CXCL1, CXCL2, CCL2, and CCL5, but not CCL20, is significantly reduced
|